Dr. Martens rebooted with the IPO and sale. Permira, fund that owns the British footwear brand, has planned to put the business on the London Stock Exchange starting next year, charging Lazard (bank), with managing the operation. At the same time, Permira could restart negotiation to sell the brand, which were interrupted due to Covid-19, with US fund Carlyle at the top of the list.
Dr. Martens reboots
Dr. Martens managed the pandemic well. Thanks to its digital channel, its sales continued to maintain a growth trend similar to those of past years. According to what reported by Reuters, citing anonymous sources close to the business, Permira has charged the bank Lazard to prepare the brand’s IPO on the LSE. The operation is scheduled to be completed in the early months of next year.
Potential sale
The same sources revealed that Permira could decide to restart negotiation to sell the brand to Carlyle. The PE fund located in the USA had sold the sneakers’ brand Golden Goose to Permira in last February. No agreement has been signed yet, but if it is to be finalized, says Reuters, it’s to happen in 2021.
Read also:
- Dr. Martens will give back the government aid received: “We don’t need it”
- Carlyle gets closer to Dr. Martens, but for how much?
